Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
Clinical trial NCT05351164 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05351164
- Sponsor
- University of Michigan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-04-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.